Notably, older age (>65), advanced stages (T3-T4, N1-N2, M1), high CEA expression, and MA/SRCC classification emerged as primary risk factors, while female gender and left colon/rectum tumors were protective, consistent with previous studies [21]. The gene discussed is CEACAM5; the disease is medical procedure.